Sigma Healthcare Ltd
ASX:SIG

Watchlist Manager
Sigma Healthcare Ltd Logo
Sigma Healthcare Ltd
ASX:SIG
Watchlist
Price: 2.795 AUD 0.18% Market Closed
Market Cap: AU$32.3B

P/FCFE

40.7
Current
17%
More Expensive
vs 3-y average of 34.9

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
40.7
=
Market Cap
AU$32.7B
/
Free Cash Flow to Equity
AU$790.2m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
40.7
=
Market Cap
AU$32.7B
/
Free Cash Flow to Equity
AU$790.2m

Valuation Scenarios

Sigma Healthcare Ltd is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (34.9), the stock would be worth AU$2.4 (14% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-87%
Maximum Upside
No Upside Scenarios
Average Downside
41%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 40.7 AU$2.8
0%
3-Year Average 34.9 AU$2.4
-14%
5-Year Average 5.2 AU$0.36
-87%
Industry Average 38.4 AU$2.64
-6%
Country Average 18.1 AU$1.24
-56%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

Higher than 75% of companies in Australia
Percentile
75th
Based on 1 160 companies
75th percentile
40.7
Low
0.2 — 12.5
Typical Range
12.5 — 35.6
High
35.6 —
Distribution Statistics
Australia
Min 0.2
30th Percentile 12.5
Median 18.1
70th Percentile 35.6
Max 5 049.1

Sigma Healthcare Ltd
Glance View

Market Cap
32.3B AUD
Industry
Health Care

In the competitive landscape of Australia’s healthcare sector, Sigma Healthcare Ltd emerges as a vital cog in the country’s pharmacy and healthcare distribution wheel. Born from a humble beginning, the company has strategically evolved into one of the leading pharmaceutical wholesalers, boasting an extensive distribution network that spans across Australia's vast geography. Sigma supplies both prescription medicines and over-the-counter products to numerous independent and branded pharmacies, including recognizable names such as Amcal and Guardian. This distribution forte encapsulates Sigma’s primary revenue stream, as the company capitalizes on the efficiency of its supply chain operations, ensuring pharmaceuticals are delivered seamlessly from manufacturers directly to the doorsteps of pharmacies and hospitals. Beyond distribution, Sigma has diversified its operations to tap into retail pharmacy franchising, leveraging well-established brands to capture consumer loyalty. Operating under its banner of pharmacy brands, Sigma extends support in the form of marketing, retail advisory, and operational assistance to its franchise network, which in turn, feeds into its profitability margins. The company's strategic foresight into expanding its retail and service offerings further underpins its financial architecture, as it looks to balance its ledger not just through wholesale operations but also via the value-added services offered to its network. By orchestrating a symphony of merchandise management, supply chain prowess, and retail consultancy, Sigma Healthcare Ltd not only sustains its market relevance but also weaves itself deeply into the fabric of Australian healthcare delivery.

SIG Intrinsic Value
1.01 AUD
Overvaluation 64%
Intrinsic Value
Price AU$2.795
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett